Navigation Links
Octapharma USA Submits BLA for octaplasLG®, a Therapy Targeting Adverse Transfusion Events
Date:2/27/2012

HOBOKEN, N.J., Feb. 27, 2012  /PRNewswire/ -- Octapharma USA has submitted its Biological License Application (BLA) for octaplasLG® to the U.S. Food and Drug Administration (FDA) with the goal of expanding its U.S. product portfolio by the fourth quarter of 2012.

The FDA will evaluate the octaplasLG® BLA for an indication of managing preoperative or bleeding patients who require replacement of multiple plasma coagulation factors. The application also seeks to gain marketing approval for the substitution of intentionally removed plasma, such as plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP), a blood disorder that causes clot formation in small blood vessels. The product features solvent/detergent inactivation against enveloped viruses and immune neutralization against non-enveloped viruses.

"We look forward to bringing octaplasLG® to the U.S. medical community," said Octapharma USA President Flemming Nielsen. "This trusted therapy has been successfully used to treat patients for more than 15 years in Europe and over 30 countries worldwide."

Octapharma USA has started to lay the groundwork for the introduction of

SOURCE Octapharma USA
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Octapharma USA Appoints Global Biopharmaceutical Executive David E. Holliday as Vice President of Commercial Development
2. Octapharma Announces octagam® 5% Again Available for U.S. Purchase
3. FDA Approves U.S. Market Return for octagam® Following Octapharmas Implementation of Enhanced Safety Measures
4. Octapharma USA to Participate in Important Medical Meetings at AABB, NHF, ASHP and ASH
5. Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients
6. Octapharma USA Sponsors International Advisory Board for Evaluating Treatment of Patients with von Willebrand Disease
7. Octapharma Targets Primary Immune Deficiency Research With Grant for The Mount Sinai Medical Center
8. Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line
9. Octapharma Accepting Applications for Research Grants Focused on Human Protein Therapies
10. Octapharma USA Launches Web Resource for von Willebrand Disease Healthcare Professionals and Patients
11. FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USAs New Therapy for Common Inherited Bleeding Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... LUXEMBOURG , May 17, 2013  ConvaTec today announced that it ... Ken Berger , CEO, and Ed Borkowski ... AM ET live via telephone. To participate in the ... (877) 366-0267. To participate in the conference call outside the ... The conference ID is 72195398. Participants should dial in ...
(Date:5/17/2013)... 17, 2013  PENTAX Medical, a healthcare industry ... global leader in ultrasound imaging, recently announced renewed ... enable further innovation in the development of Endoscopic ... systems and PENTAX Medical endoscopic portfolio have formed ... EUS systems. This agreement will continue to grow ...
(Date:5/17/2013)... Mass. , May 17, 2013  Boston Scientific ... participate at the annual EuroPCR Scientific Program May 21-24 ... are pleased to present a particularly rich and diversified ... Keith Dawkins , M.D., global chief medical ... trials will be presented, including the NG PROMUS trial, ...
Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
... Accuray Incorporated (Nasdaq: ARAY ), a global ... management is scheduled to present at the JMP Securities Healthcare ... at 11:30 a.m. ET/8:30 a.m. PT. A live ... investor relations page of the Company,s Web site at ...
... Boston Scientific Corporation (NYSE: BSX ) ... under which Boston Scientific will acquire Asthmatx, Inc., a ... and markets a less-invasive, catheter-based bronchial thermoplasty procedure for ... to 8 million patients 18 years and older worldwide ...
Cached Medicine Technology:Accuray Incorporated to Speak at JMP Securities Healthcare Conference 2Boston Scientific to Acquire Asthmatx 2Boston Scientific to Acquire Asthmatx 3Boston Scientific to Acquire Asthmatx 4Boston Scientific to Acquire Asthmatx 5
(Date:5/19/2013)... May 19, 2013 The report “Feed ... Trends & Forecasts up to 2017” published by MarketsandMarkets, ... with analysis and forecasting of the global volume and ... the driving and restraining factors for the global market ... and challenges. The market is segmented and revenue is ...
(Date:5/19/2013)... 19, 2013 Farming methods have changed ... the ground 10,000 years ago. Most recently, the Green ... by using genetically engineered seeds and by applying chemical ... backlash to these techniques due to the adverse environmental ... a corresponding surge in interest in organic, sustainable farming ...
(Date:5/19/2013)... Yeast infections are common in both men and ... the human body. A new yeast infection treatment product has ... unique method of application to help eliminate over growth of ... to men and women searching for a natural process of ... through food and is stored in the intestines. In small ...
(Date:5/19/2013)... Beginning Wednesday, May 29 and running through Wednesday, August 28, ... Dog Wednesdays" and Ice Cold Slushies at donor centers in ... all the fixin's to donors on Wednesdays. RRVBC will ... are our lifeline. The summer months are an especially challenging ... This is a small way for us to thank our ...
(Date:5/19/2013)... 2013 Minor fender benders and serious ... require parties to the accident to respond appropriately to ... and Prevention (CDC) data from 2010, accidents, including car ... In fact, in 2005, automobile accident-related deaths ... more than 2.3 million drivers and passengers receive treatment ...
Breaking Medicine News(10 mins):Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2
... The following is a statement from Georges C. ... the American Public Health Association:"The American Public Health ... Dr. Thomas Frieden as the new director of ... his tenure as New York City,s health commissioner, ...
... WASHINGTON , May 15 Americans United for ... the probable "short list" of President Obama,s Supreme Court ... the nation,s first national pro-life organization and the leading ... , , The comprehensive, concise ...
... Application to Offer Single Platform for AF Patient ... www.ecardio.com ) announced the launch of ... at Heart Rhythm 2009, the Annual Scientific Sessions ... an informatics solution that presents a longitudinal view ...
... Efforts to Expand Treatment Options for Patients with PKUNOVATO, ... BMRN ) announced today that it has received ... Rare Disorders (NORD), an organization dedicated to improving the ... presented on May 14 at NORD,s annual "Partners in ...
... Meanwhile, world health officials discuss strategy for a vaccine ... troubling sign that the swine flu outbreak has yet ... three New York City public schools were closed Thursday ... principal was in critical condition on a ventilator, according ...
... Mattar team to improve nation,s healthCARMEL, Ind., May 15 ... his weight loss journey with over 400 current and former ... the East Chalet at the Indianapolis Motor Speedway on Friday, ... track, but was struggling to keep up in his personal ...
Cached Medicine News:Health News:Americans United for Life Announces Legal Prospectus on Probable Supreme Court Nominees 2Health News:Americans United for Life Announces Legal Prospectus on Probable Supreme Court Nominees 3Health News:eCardio Launches NEW Atrial Fibrillation Information System (AFIS(TM)) 2Health News:BioMarin Receives 2009 Corporate Award for the Development of Kuvan 2Health News:BioMarin Receives 2009 Corporate Award for the Development of Kuvan 3Health News:BioMarin Receives 2009 Corporate Award for the Development of Kuvan 4Health News:Swine Flu Closes 3 Schools in NYC 2Health News:Swine Flu Closes 3 Schools in NYC 3Health News:Swine Flu Closes 3 Schools in NYC 4Health News:Swine Flu Closes 3 Schools in NYC 5Health News:Swine Flu Closes 3 Schools in NYC 6Health News:Swine Flu Closes 3 Schools in NYC 7Health News:Swine Flu Closes 3 Schools in NYC 8Health News:Swine Flu Closes 3 Schools in NYC 9Health News:Swine Flu Closes 3 Schools in NYC 10Health News:400 People Join Panther Racing CEO and Physician to Celebrate Improved Health and Quality of Life 2Health News:400 People Join Panther Racing CEO and Physician to Celebrate Improved Health and Quality of Life 3